Global Women Healthcare Market – Overview
With the growing awareness of early diagnosis, advanced treatment and growing novel drugs to treat the women health disorders among the patients and healthcare professionals has supported the growth of the market. The health of women is of particular concern as in many societies women are disadvantaged by discrimination rooted in sociocultural factors. For instance, women and girls face increased vulnerability to HIV/AIDS.
Get Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/3121
Globally, women healthcare market is dominated by several major players such as Allergan, Amgen, Bayer, BD, Eli Lily, Merck, Pfizer, Teva Pharmaceuticals and others. APAC region was the most benefited region due to the rising prevalence of the disease and rising number of treatment for women associated diseases and increasing advanced devices and therapeutics for gynecological disorders. The market for women healthcare is projected to grow at a steady CAGR of 5.04% during the forecast period from 2017-2023.
Market Segmentation
In MRFR’s report, the women healthcare market has been segmented on the basis of indications, diagnosis, treatment and end-users.
Based on indications, it is segmented into gynecologic cancer, polycystic ovary syndrome, reproductive health management, infertility and postmenopausal osteoporosis. Gynecologic cancer is further segmented into ovarian and breast cancer. Of these, postmenopausal osteoporosis holds the maximum market share on account of increase in female population aged above 40 years along with launch of new drugs for treating menopausal osteoporosis. The presence of a good number of leading players coupled with ongoing Research and Development (R&D) is predicted to boost the growth of this segment over the forecast period.
Based on diagnosis, the women healthcare market is segmented into ovulation testing, biopsies, diagnostic imaging tests and bone densitometry.
Based on treatment, it is segmented into surgeries and therapeutics.
Based on end-users, the women healthcare market is segmented into research institutes, gynecology centers, hospitals and clinics. Of these, the hospitals and clinics hold the maximum market share due to higher proportion of women patients visiting hospitals for diagnosis as well as treatment of health issues.
Women Healthcare Market - Regional Analysis
North America leads the global women healthcare market, due to the increasing initiatives promoting women’s health and wellness. Additionally, the presence of well-developed healthcare infrastructure and leading players is supporting the regional market growth. Also, increasing emphasis on diagnosis and continuous monitoring of diseases associated with women, especially propel the growth of the regional market.
Furthermore, the high prevalence of various chronic diseases among women and the funding support from the companies, private organization, and government associations to improve women healthcare in the region drive the growth of the regional market.
The women healthcare market in the European region takes the second leading position. The resurging economy plays an important role in supporting the growth of the regional market, availing the best possible healthcare and increasing the per capita healthcare expenditures specially designed for women. Besides, government support that encourages the players to develop high-quality technologies for women’s health and wellness and favorable reimbursement policies are fostering the growth in the regional market.
The Asia Pacific women healthcare market is rapidly emerging as a profitable market globally. The prevalence of chronic diseases among women populaces is a key driving force behind the regional market growth. Moreover, factors such as the proliferating healthcare sector and spreading awareness among individuals towards women’s health and wellness and the availability of various care units drive the growth of the market in the region.
Women Healthcare Market Key Players
Key players profiled in the global women healthcare market report include Teva Pharmaceuticals (Israel), Pfizer Inc., (US), Merck & Co., Inc., (US), Eli Lilly Company (US), Becton Dickinson and Company (US), Bayer AG (Germany), Amgen (California), and Allergan plc. (Ireland).
Global Competitive Analysis
The market value of the industry has been enhanced by the constantly delivery of customer value. The market contenders are devising their blueprints for corporate strategy in a way can bring about the best outcomes for development in the current scenario, while also concurrently enhancing their product’s value. The opportunity for development in the industry appears to be promising through the forecast period. The capability to fuel competitive capabilities is one of the chief causes powering their efforts in this period. The escalating levels of diversification in the industry, have allowed the companies to utilize many opportunities available in the industry. The firms in this market are adapting to the state of events by implementing portfolio upgrades and maintaining financial liquidity. Moreover, the contenders are handling the competitive environment by driving the market growth factors to their advantage.
The industry for women healthcare globally includes important contenders such as Becton Dickinson and Company (U.S.), Eli Lilly Company (U.S.), Allergan plc. (Ireland), Bayer A G (Germany), Amgen (California), Pfizer Inc., (U.S.), Teva Pharmaceuticals (Israel) and Merck & Co., Inc., (U.S.).
List Of Figures
FIGURE 1 GLOBAL WOMEN HEALTHCARE MARKET: MARKET STRUCTURE 17
FIGURE 2 RESEARCH PROCESS 18
FIGURE 3 GLOBAL WOMEN HEALTHCARE MARKET: PORTERS FIVE FORCES MODEL 25
FIGURE 4 GLOBAL WOMEN HEALTHCARE MARKET: VALUE CHAIN ANALYSIS 27
FIGURE 5 GLOBAL WOMEN HEALTHCARE MARKET, BY INDICATION, 2020 & 2027 (USD MILLION) 30
FIGURE 6 GLOBAL WOMEN HEALTHCARE MARKET, BY DIAGNOSIS & TREATMENT, 2020 & 2027 (USD MILLION) 38
Browse Complete Report @ https://www.marketresearchfuture.com/reports/women-healthcare-market-3121
Related reports link:-
Diabetic Retinopathy Market
Healthcare Cloud Computing Market
Acute Care EHR Market
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
